Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
Ophthalmic Surgery, Lasers & Imaging Retina
|
July 17, 2015
Retinal Pigment Epithelial Adenocarcinoma Presenting as an Amelanotic Mass
Kendra A Klein, David R Lally, Lauren S Taney, et al.
Journal of Pediatric Ophthalmology and Strabismus
|
February 22, 2008
Pigmented free-floating vitreous cyst in a child
David R Lally, Jerry F Shields, Carol L Shields, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie
|
April 29, 2014
Pulmonary nocardiosis initially manifesting as endogenous endophthalmitis
David R Lally, Dinesh K Sharma, Carol L Shields, et al.
Ocular Oncology and Pathology
|
February 1, 2020
Choroidal Melanoma Simulating Adenoma of the Retinal Pigment Epithelium Arising at the Site of Congenital Hypertrophy of the Retinal Pigment Epithelium
Basil K Williams, Maura Di Nicola, J Antonio Lucio-Alvarez, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
January 6, 2016
Optical Coherence Tomography Angiography for Detecting Choroidal Neovascularization Secondary to Choroidal Osteoma
Jason T Szelog, Marco A Bonini Filho, David R Lally, et al.
Retinal Cases & Brief Reports
|
November 20, 2015
A UNIQUE POSTERIOR SEGMENT PHENOTYPIC MANIFESTATION OF COXSACKIE VIRUS INFECTION
Chandrakumar Balaratnasingam, David R Lally, Kirstin L Tawse, et al.
BMC Ophthalmology
|
June 10, 2022
Evaluation of a self-imaging SD-OCT system designed for remote home monitoring
Judy E Kim, Oren Tomkins-Netzer, Michael J Elman, et al.
Eye (London, England)
|
June 8, 2022
Correction: Efficacy and safety of brolucizumab versus aflibercept in eyes with early persistent retinal fluid: 96-week outcomes from the HAWK and HARRIER studies
David R Lally, Anat Loewenstein, Jennifer J Arnold, et al.
Eye (London, England)
|
May 21, 2022
Efficacy and safety of brolucizumab versus aflibercept in eyes with early persistent retinal fluid: 96-week outcomes from the HAWK and HARRIER studies
David R Lally, Anat Loewenstein, Jennifer J Arnold, et al.
JAMA Ophthalmology
|
February 25, 2021
Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration
Ana Bety Enríquez, Caroline R Baumal, Ashley M Crane, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
Ophthalmic Surgery, Lasers & Imaging Retina
|
July 17, 2015
Retinal Pigment Epithelial Adenocarcinoma Presenting as an Amelanotic Mass
Kendra A Klein, David R Lally, Lauren S Taney, et al.
Journal of Pediatric Ophthalmology and Strabismus
|
February 22, 2008
Pigmented free-floating vitreous cyst in a child
David R Lally, Jerry F Shields, Carol L Shields, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie
|
April 29, 2014
Pulmonary nocardiosis initially manifesting as endogenous endophthalmitis
David R Lally, Dinesh K Sharma, Carol L Shields, et al.
Ocular Oncology and Pathology
|
February 1, 2020
Choroidal Melanoma Simulating Adenoma of the Retinal Pigment Epithelium Arising at the Site of Congenital Hypertrophy of the Retinal Pigment Epithelium
Basil K Williams, Maura Di Nicola, J Antonio Lucio-Alvarez, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
January 6, 2016
Optical Coherence Tomography Angiography for Detecting Choroidal Neovascularization Secondary to Choroidal Osteoma
Jason T Szelog, Marco A Bonini Filho, David R Lally, et al.
Retinal Cases & Brief Reports
|
November 20, 2015
A UNIQUE POSTERIOR SEGMENT PHENOTYPIC MANIFESTATION OF COXSACKIE VIRUS INFECTION
Chandrakumar Balaratnasingam, David R Lally, Kirstin L Tawse, et al.
BMC Ophthalmology
|
June 10, 2022
Evaluation of a self-imaging SD-OCT system designed for remote home monitoring
Judy E Kim, Oren Tomkins-Netzer, Michael J Elman, et al.
Eye (London, England)
|
June 8, 2022
Correction: Efficacy and safety of brolucizumab versus aflibercept in eyes with early persistent retinal fluid: 96-week outcomes from the HAWK and HARRIER studies
David R Lally, Anat Loewenstein, Jennifer J Arnold, et al.
Eye (London, England)
|
May 21, 2022
Efficacy and safety of brolucizumab versus aflibercept in eyes with early persistent retinal fluid: 96-week outcomes from the HAWK and HARRIER studies
David R Lally, Anat Loewenstein, Jennifer J Arnold, et al.
JAMA Ophthalmology
|
February 25, 2021
Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration
Ana Bety Enríquez, Caroline R Baumal, Ashley M Crane, et al.
Page
of 5